Safety and weight reduction of sibutramine in the treatment of Thai obese and overweight subjects
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 14 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 14 Jul 2008 The actual completion date for this trial is now 1 Jan 2006 as reported by ClinicalTrials.gov
- 25 Jun 2007 New trial record.